Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**triiodothyronine + C15** appears to denote a proposed combination of triiodothyronine and a substance identified only as C15. Triiodothyronine is the active thyroid hormone T3 and functions primarily as an agonist of thyroid hormone receptors to increase transcriptional programs controlling basal metabolic rate, thermogenesis, lipid and carbohydrate metabolism, and cardiovascular activity. However, the identity of the accompanying component \"C15\" is not specific from the query alone and could refer to different entities, most commonly pentadecanoic acid or another C15-designated compound; no clearly established, recognized pharmaceutical product or development program corresponding specifically to the exact combination \"triiodothyronine + C15\" could be confirmed from the provided name alone. As a result, this entry is best treated as a nonspecific putative combination rather than a validated named drug product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on triiodothyronine + C15.